The study’s primary focus was on pathological differences between tumor and adjacent normal tissues, with RCOR2 found to be significantly overexpressed in endometrial cancer and associated with adverse clinicopathological features, including stage, grade, and lymph node metastasis. The gene discussed is RCOR2; the disease is endometrial cancer.